Table 4.
Biomarkers (levels) |
Hypertension | Dyslipidemia | Hyperglycemia | Overweight or Obesity |
Central Obesity |
---|---|---|---|---|---|
hsCRP, mg/L | |||||
<3.95 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
3.95–11.38 | 1.32 (1.05, 1.66) | 0.98 (0.81, 1.19) | 0.80 (0.62, 1.03) | 1.87 (1.48, 2.39) | 1.82 (1.48, 2.25) |
>11.38 | 1.96 (1.52, 2.53) | 2.33 (1.85, 2.94) | 2.95 (2.27, 3.83) | 3.27 (2.50, 4.27) | 3.34 (2.62, 4.26) |
Trend P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
sE-selectin, ng/mL | |||||
<14.78 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
14.78–24.83 | 1.40 (1.13, 1.73) | 1.12 (0.94, 1.35) | 1.39 (1.11, 1.74) | 1.11 (0.89, 1.37) | 1.14 (0.94, 1.39) |
>24.83 | 1.35 (1.05, 1.72) | 1.24 (1.00, 1.54) | 1.09 (0.83, 1.43) | 2.10 (1.64, 2.67) | 1.82 (1.45, 2.29) |
Trend P value | 0.013 | 0.048 | 0.291 | <0.001 | <0.001 |
Angiotensin II, pg/mL | |||||
<40.0 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
40.0–71.3 | 1.26 (1.01, 1.57) | 0.96 (0.79, 1.16) | 1.50 (1.18, 1.91) | 0.85 (0.69, 1.06) | 1.00 (0.82, 1.21) |
>71.3 | 1.81 (1.40, 2.33) | 0.86 (0.69, 1.08) | 1.17 (0.88, 1.56) | 0.93 (0.72, 1.19) | 1.05 (0.83, 1.33) |
Trend P value | <0.001 | 0.189 | 0.306 | 0.543 | 0.683 |
sICAM-1, ng/mL | |||||
<230.96 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
230.96–426.78 | 1.03 (0.83, 1.29) | 1.05 (0.87, 1.27) | 1.24 (0.96, 1.59) | 0.99 (0.79, 1.23) | 0.92 (0.75, 1.12) |
>426.78 | 1.29 (0.96, 1.73) | 1.70 (1.30, 2.22) | 2.80 (2.06, 3.80) | 1.36 (1.02, 1.82) | 1.23 (0.86, 1.48) |
Trend P value | 0.126 | 0.001 | <0.001 | 0.070 | 0.557 |
Note. The multivariate model included biomarkers groups, age, gender, current smoking, current drinking, family history of CVD, hypertension, hyperglycemia, dyslipidemia, overweight or obesity, and central obesity. The three levels of all the biomarkers were categorized as the low/up quartiles: <25%, 25%–75%, and >75%.